Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ABBOTT LABORATORIES Stock Hits Price Target Forecast with 17.28% Profit

February 20, 2025
Abbott Laboratories (ABT) has recently achieved its price target forecast of 132.56 $, signaling a successful long trade with a profit of 17.28%. The forecast, issued by QuantWave on December 11, 2024, at a price of 113.02 $, has come to fruition on February 20, 2025. This significant price movement underscores the accuracy and effectiveness of QuantWave's analytics in predicting stock movements.

Market analysis indicates that ABBOTT LABORATORIES has experienced positive momentum driven by strong financial performance and market sentiment. Factors such as robust sales growth, innovative product developments, and strategic acquisitions have boosted investor confidence in the company's future prospects. Additionally, favorable industry trends and a solid management team have contributed to the stock's upward trajectory.

QuantWave's achievement of its price target forecast for ABBOTT LABORATORIES highlights the platform's ability to provide valuable insights for investors seeking to capitalize on market opportunities. With a proven track record of accurate predictions, QuantWave offers a reliable source of investment guidance for traders looking to enhance their portfolio performance.

For those interested in exploring further investment opportunities, QuantWave provides access to forecasts for a wide range of stocks, presenting potential avenues for generating profits. Investors can benefit from leveraging QuantWave's automated forecasting platform to make informed trading decisions and maximize their returns.

To deepen understanding of QuantWave's investment strategy, individuals are encouraged to explore the educational offerings of QuantSchool. QuantSchool offers a comprehensive professional investment framework that reveals key principles for achieving consistent income using the QuantWave forecasting system, empowering investors to navigate the financial markets with confidence and precision.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTAugust 9, 2025Abbott Laboratories NYSE:ABT Earnings Are Of Questionable Quality  ~1 min.

Abbott Laboratories recently reported their second quarter 2025 earnings, with EPS exceeding expectations....


ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....


ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....


ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....


ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....


ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....


ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....


ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....


ABTOctober 12, 2023ABBOTT LABORATORIES Hits Forecast Price Target with 10.91% Profit, Confirming QuantWave's Accuracy  ~2 min.

Abbott Laboratories (NYSE: ABT) recently achieved the forecast price target set by QuantWave, signaling a profitable short position for investors....


ABTJanuary 10, 2024ABBOTT LABORATORIES Hits QuantWave Forecast Target with 9.63% Profit  ~1 min.

On December 5, 2023, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock, which was trading at $100.85 at the time....


ABTFebruary 28, 2024ABBOTT LABORATORIES Stock Hits Forecasted Price Target with 13.42% Profit  ~2 min.

On July 18, 2023, QuantWave's forecast signal predicted a long position for ABBOTT LABORATORIES stock when it was trading at $102.80....


ABTFebruary 20, 2025ABBOTT LABORATORIES Stock Hits Price Target Forecast with 15.12% Profit, QuantWave Analysis Shows Strong Predictive Power  ~2 min.

ABBOTT LABORATORIES (NYSE: ABT) investors reaped substantial gains as the stock price hit the forecasted target of 132.56 $ on February 20, 2025, resulting in a profit of 15.12%....


ABTFebruary 22, 2024ABBOTT LABORATORIES Hits Price Target Forecast with 12.4% Profit Gain  ~1 min.

On July 11, 2023, QuantWave's forecast signal for ABBOTT LABORATORIES indicated a long position with a price of $102.83. Fast forward to February 22, 2024, the target price of $115....